Skip to main content
OpenTrials

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

397 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Histiocytosis trial results

Completed

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

NCT02004691

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • UCSF Medical Center Site Number : 840005 San Francisco, California, United States
  • Emory University Site Number : 840003 Decatur, Georgia, United States
  • Montefiore Medical Center Site Number : 840006 The Bronx, New York, United States
  • Investigational Site Number : 032001 Córdoba, Argentina
View all 24 locations
View Trial Details
Completed

A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

NCT02004704

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • Investigational Site Number 840001 New York, United States
  • Investigational Site Number 056001 Leuven, Belgium
  • Investigational Site Number 076001 Porto Alegre, Brazil
  • Investigational Site Number 250002 Bron, France
View Trial Details
Completed

A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT04231747

Conditions
Agressive Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse-large B-cell Lymphoma (DLBCL), +13 more
Locations
  • Local Institution - 003 Birmingham, Alabama, United States
  • Local Institution - 004 Atlanta, Georgia, United States
  • Local Institution - 011 Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis

NCT03312751

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Non-Langerhans-Cell, +3 more
Locations
  • Phoenix Children Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Alfred I. duPont Hospital for Children - Nemours Center for Cancer and Blood Disorders - Division of Pediatric Hematology Oncology Wilmington, Delaware, United States
View all 27 locations
View Trial Details
Completed

N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)

NCT03759639

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Giessen Giessen, Germany
  • Ludwig Maximilian University of Munich München, Germany
  • Comenius University in Bratislva Bratislava, Slovakia
View Trial Details

Related conditions